Royal Fund Management’s Vanguard Health Care ETF VHT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.5M Buy
35,235
+2,114
+6% +$588K 0.88% 29
2026
Q1
$9.03M Buy
33,121
+1,935
+6% +$553K 0.86% 29
2025
Q4
$8.99M Buy
31,186
+7,705
+33% +$2.15M 0.82% 36
2025
Q3
$6.11M Sell
23,481
-4,495
-16% -$1.13M 0.73% 40
2025
Q2
$6.96M Buy
27,976
+400
+1% +$98.9K 0.69% 40
2025
Q1
$7.37M Sell
27,576
-26,676
-49% -$7.11M 0.82% 26
2024
Q4
$13.9M Buy
54,252
+2,374
+5% +$640K 1.3% 13
2024
Q3
$14.8M Buy
51,878
+27,353
+112% +$7.6M 0.88% 24
2024
Q2
$6.58M Sell
24,525
-8,175
-25% -$2.14M 0.53% 31
2024
Q1
$8.86M Buy
32,700
+723
+2% +$190K 0.87% 21
2023
Q4
$8.03M Buy
31,977
+644
+2% +$153K 0.89% 24
2023
Q3
$7.37M Buy
31,333
+1,454
+5% +$354K 1% 25
2023
Q2
$7.32M Buy
29,879
+746
+3% +$181K 0.91% 27
2023
Q1
$6.95M Buy
29,133
+203
+0.7% +$48.9K 0.99% 26
2022
Q4
$7.18M Buy
28,930
+506
+2% +$123K 1.14% 22
2022
Q3
$6.36M Sell
28,424
-944
-3% -$225K 1.16% 21
2022
Q2
$6.92M Sell
29,368
-1,039
-3% -$250K 1.15% 21
2022
Q1
$7.74M Buy
30,407
+721
+2% +$178K 1.12% 25
2021
Q4
$7.91M Buy
29,686
+1,997
+7% +$509K 1.13% 24
2021
Q3
$6.84M Buy
27,689
+1,718
+7% +$441K 1% 33
2021
Q2
$6.42M Buy
25,971
+2,434
+10% +$582K 1.06% 30
2021
Q1
$5.38M Buy
23,537
+2,899
+14% +$665K 0.98% 33
2020
Q4
$4.62M Buy
20,638
+4,344
+27% +$929K 0.98% 34
2020
Q3
$3.32M Buy
16,294
+6,884
+73% +$1.39M 0.85% 53
2020
Q2
$1.81M Buy
9,410
+3,002
+47% +$563K 0.64% 65
2020
Q1
$1.06M Buy
6,408
+1,764
+38% +$322K 0.43% 62
2019
Q4
$890K Buy
4,644
+1,944
+72% +$349K 0.23% 73
2019
Q3
$452K Buy
2,700
+773
+40% +$132K 0.13% 84
2019
Q2
$335K Buy
1,927
+481
+33% +$81.2K 0.1% 101
2019
Q1
$249K Buy
1,446
+650
+82% +$110K 0.08% 113
2018
Q4
$127K Buy
796
+700
+729% +$119K 0.05% 137
2018
Q3
$17K Hold
96
0.01% 290
2018
Q2
$15K Buy
96
+84
+700% +$13.2K 0.01% 313
2018
Q1
$1K Buy
+12
New +$1.92K ﹤0.01% 507

Other funds holding VHT

Royal Fund Management's VHT Position: Q2 2026 in Review

Royal Fund Management increased its Vanguard Health Care ETF (VHT) stake by 6.4% in Q2 2026, buying an estimated $588K and bringing the position to 35,235 shares worth $10.5M. The position accounts for 0.88% of the portfolio, ranked #29.

Royal Fund Management first reported a position in VHT in Q1 2018 and has held it in 34 quarters since. The position peaked at $14.8M in Q3 2024. 212 funds tracked by Wall St. Rank hold VHT as of Q2 2026.

  • Royal Fund Management held 35,235 shares of Vanguard Health Care ETF worth $10.5M as of Q2 2026.
  • Royal Fund Management bought 2,114 Vanguard Health Care ETF shares in Q2 2026, an estimated $588K.
  • Vanguard Health Care ETF made up 0.88% of Royal Fund Management's portfolio in Q2 2026, its #29 holding.
  • Royal Fund Management first reported a position in Vanguard Health Care ETF in Q1 2018 and has held it in 34 quarters since.
  • Royal Fund Management's Vanguard Health Care ETF position peaked at $14.8M in Q3 2024.
  • 212 funds tracked by Wall St. Rank held Vanguard Health Care ETF as of Q2 2026.

Based on Royal Fund Management's 13F filing for Q2 2026, filed 20 Jul 2026.